Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Early recognition and treatment of Peripheral Arterial Disease is crucial to improve survival and health outcomes.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

A certain gene variation can affect protein production and is linked to male pattern baldness.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

TA-Ado effectively promotes hair growth and reduces hair loss.

4‐MAPC reduces rat prostate weight and prostatein levels.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

ADEM is a sudden brain disorder often following infection or vaccination, diagnosed by ruling out other conditions.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

AGD1's PH domain is essential for its role in root hair growth and polarity.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Precocious puberty can signal familial adenomatous polyposis.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.